ARCHIVES

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

March 15, 1985

Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects

November 26, 1999

Gleevec Approved For Pediatric CML

May 23, 2003

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011